Auro Laboratories Profit & Loss Annual

Trade
BSE: 530233 | NSE: - | ISIN: INE292C01011 | Sector: Biotechnology & Drugs
207.40 +7.80 (3.91%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 53.6452.8950.8754.25
Total Revenue 53.6452.8950.8754.25
Costof Revenue Total 26.5635.6932.7828.55
Gross Profit 27.0817.2018.0825.70
Selling/ General/ Admin Expenses Total 5.144.726.246.04
Depreciation/ Amortization 1.091.071.021.04
Other Operating Expenses Total 11.268.087.228.43
Total Operating Expense 44.0649.5847.2644.05
Operating Income 9.583.323.6110.21
Interest Inc( Exp) Net- Non- Op Total -7.36-7.30-5.49-3.12
Other Net 1.500.860.810.61
Net Income Before Taxes 10.353.453.8710.51
Provisionfor Income Taxes 2.551.001.033.33
Net Income After Taxes 7.792.442.847.18
Net Income Before Extra Items 7.792.442.847.18
Net Income 7.792.442.847.18
Total Adjustmentsto Net Income 0.000.00--
Income Availableto Com Excl Extra Ord 7.792.442.847.18
Income Availableto Com Incl Extra Ord 7.792.442.847.18
Diluted Net Income 7.792.442.847.18
Diluted Weighted Average Shares 0.620.620.620.62
Diluted EPS Excluding Extra Ord Items 12.503.924.5611.52
Diluted Normalized EPS 12.503.924.5611.52
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts